Search

April L Bernacki

from Eugene, OR
Age ~46
Get Report
Also known as:
April Lavonne Bernacki, April Lavonne Dowdy, April L Dowdy, April L Beracki
Related to:
Wanda M Dowdy, 97Thomas R BernackiDarla J Dowdy, 67Caleb N Ratliff, 42Kassandra D Dowdy, 42Jeffrey T Bernacki, 47Steven M Bernacki, 43Paul J Dowdy, 67Danae T Dowdy, 37Margaret E Dowdy, 89Janet M Bernacki, 73Helen M DowdyThomas R Bernacki, 79
Connected to:
Bernadette L Bernaciak, 60Carmen G Bernacki, 68Jessica M Bernache, 42Matias G Bernachea, 47Peter D Bernaciak, 62Phillip E Bernache, 75Sheri M Bernacki, 64Jose F Bernad, 61Maria E Bernadac, 54Matthew J Bernad, 76

April Bernacki Phones & Addresses

  • Eugene, OR
  • 38418 Dexter Rd, Dexter, OR 97431 (720) 684-6790
  • 2224 Whistler Dr, Longmont, CO 80501 (720) 684-6790
  • 1257 Fall River Cir, Longmont, CO 80501 (303) 485-8115
  • 3803 Morgan St, South Bend, IN 46628 (574) 277-8643

Work

Company: Array biopharma Oct 2010 Position: Staff scientist

Education

School / High School: University of Notre Dame 1999 to 2002 Specialities: Organic Chemistry

Skills

Organic Chemistry • Medicinal Chemistry • Drug Discovery • Gmp • Synthetic Organic Chemistry • Crystallization • Chemistry • Lc Ms • Small Molecules • Organic Synthesis • Glp • Drug Design • Nmr • Hplc • Inflammation • Drug Development • Pharmaceutical Industry • Technology Transfer • Chromatography • Purification • Process Chemistry • Parallel Synthesis • Cmc • R

Industries

Pharmaceuticals

Resumes

Resumes

April Bernacki Photo 1

Director, Business Operations

View page
Location:
802 Cheswich Ct southeast, Marietta, GA 30067
Industry:
Pharmaceuticals
Work:
Array BioPharma since Oct 2010
Staff Scientist
Array BioPharma Oct 2007 - Oct 2010
Associate Scientist
Array BioPharma Feb 2005 - Oct 2007
Research Associate III
Array BioPharma Sep 2003 - Feb 2005
Research Associate II
Array BioPharma Jun 2002 - Sep 2003
Research Associate I
Education:
University of Notre Dame 1999 - 2002
University of Oregon 1995 - 1999
BS, Biochemistry
Skills:
Organic Chemistry
Medicinal Chemistry
Drug Discovery
Gmp
Synthetic Organic Chemistry
Crystallization
Chemistry
Lc Ms
Small Molecules
Organic Synthesis
Glp
Drug Design
Nmr
Hplc
Inflammation
Drug Development
Pharmaceutical Industry
Technology Transfer
Chromatography
Purification
Process Chemistry
Parallel Synthesis
Cmc
R

Publications

Us Patents

Akt Protein Kinase Inhibitors

View page
US Patent:
20100168123, Jul 1, 2010
Filed:
Sep 25, 2009
Appl. No.:
12/567258
Inventors:
Ian S. Mitchell - Lafayette CO, US
Keith L. Spencer - Lyons CO, US
Peter Stengel - Longmont CO, US
Yongxin Han - Longmont CO, US
Nicholas C. Kallan - Boulder CO, US
Mark Munson - Louisville CO, US
Guy P.A. Vigers - Boulder CO, US
James Blake - Longmont CO, US
Anthony Piscopio - Longmont CO, US
John Josey - Longmont CO, US
Scott Miller - Longmont CO, US
Dengming Xiao - Longmont CO, US
Rui Xu - Longmont CO, US
Chang Rao - Waltham MA, US
Bing Wang - Longmont CO, US
April L. Bernacki - Longmont CO, US
International Classification:
A61K 31/497
C07D 401/04
C07D 471/04
C07D 403/04
C07D 487/04
A61K 31/437
A61P 35/00
US Classification:
51425217, 544293, 546113, 544295, 544362, 544280, 544279, 544262, 514300, 51425214, 51425216
Abstract:
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula:where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

Akt Protein Kinase Inhibitors

View page
US Patent:
20050130954, Jun 16, 2005
Filed:
Nov 19, 2004
Appl. No.:
10/993173
Inventors:
Ian Mitchell - Lafayette CO, US
Keith Spencer - Lyons CO, US
Peter Stengel - Longmont CO, US
Yongxin Han - Longmont CO, US
Nicholas Kallan - Boulder CO, US
Mark Munson - Louisville CO, US
Guy Vigers - Boulder CO, US
James Blake - Longmont CO, US
Anthony Piscopio - Longmont CO, US
John Josey - Longmont CO, US
Scott Miller - Longmont CO, US
Dengming Xiao - Longmont CO, US
Riu Xu - Longmont CO, US
Chang Rao - Waltham MA, US
Bin Wang - Longmont CO, US
April Bernacki - Longmont CO, US
International Classification:
A61K031/53
A61K031/519
A61K031/496
US Classification:
514210210, 514264100, 514256000, 514249000, 514248000, 514266200, 514246000, 514314000, 514252160, 514253060, 544279000, 544182000, 544284000, 544363000, 546122000, 546117000, 514300000
Abstract:
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula: A-L-CR where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.

Akt Protein Kinase Inhibitors

View page
US Patent:
20160152576, Jun 2, 2016
Filed:
Jan 31, 2014
Appl. No.:
14/170272
Inventors:
- Boulder CO, US
Keith L. Spencer - Boulder CO, US
Peter Stengel - Boulder CO, US
Yongxin Han - Boulder CO, US
Nicolas C. Kallan - Boulder CO, US
Mark Munson - Boulder CO, US
Guy P.A. Vigers - Boulder CO, US
James Blake - Boulder CO, US
Anthony Piscopio - Boulder CO, US
John Josey - Boulder CO, US
Scott Miller - Boulder CO, US
Dengming Xiao - Boulder CO, US
Rui Xu - Boulder CO, US
Chang Rao - Boulder CO, US
Bing Wang - Boulder CO, US
April L. Bernacki - Boulder CO, US
Assignee:
Array BioPharma, Inc. - Boulder CO
International Classification:
C07D 239/94
C07D 403/12
C07D 495/04
C07D 491/048
C07D 231/56
C07D 401/12
C07D 409/04
C07D 401/04
C07D 409/12
C07D 487/04
Abstract:
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula:where CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Control profile
April L Bernacki from Eugene, OR, age ~46 Get Report